These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32912389)

  • 21. Hospital treatment of severe acute exacerbation of chronic obstructive pulmonary disease in COVID-19 situation: back to basics.
    Upadhya P; Vadala R; A A
    Monaldi Arch Chest Dis; 2020 Sep; 90(4):. PubMed ID: 32960000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The first consecutive 5000 patients with Coronavirus Disease 2019 from Qatar; a nation-wide cohort study.
    Omrani AS; Almaslamani MA; Daghfal J; Alattar RA; Elgara M; Shaar SH; Ibrahim TBH; Zaqout A; Bakdach D; Akkari AM; Baiou A; Alhariri B; Elajez R; Husain AAM; Badawi MN; Abid FB; Abu Jarir SH; Abdalla S; Kaleeckal A; Choda K; Chinta VR; Sherbash MA; Al-Ismail K; Abukhattab M; Ait Hssain A; Coyle PV; Bertollini R; Frenneaux MP; Alkhal A; Al-Kuwari HM
    BMC Infect Dis; 2020 Oct; 20(1):777. PubMed ID: 33076848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 and diabetes: Is there enough evidence?
    Tadic M; Cuspidi C; Sala C
    J Clin Hypertens (Greenwich); 2020 Jun; 22(6):943-948. PubMed ID: 32472662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19 and nicotine as a mediator of ACE-2.
    Leung JM; Yang CX; Sin DD
    Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32350104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for the exacerbation of patients with 2019 Novel Coronavirus: A meta-analysis.
    Zhao J; Li X; Gao Y; Huang W
    Int J Med Sci; 2020; 17(12):1744-1750. PubMed ID: 32714077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March-April 2020.
    Ferguson J; Rosser JI; Quintero O; Scott J; Subramanian A; Gumma M; Rogers A; Kappagoda S
    Emerg Infect Dis; 2020 Aug; 26(8):1679-1685. PubMed ID: 32407284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Underlying respiratory diseases, specifically COPD, and smoking are associated with severe COVID-19 outcomes: A systematic review and meta-analysis.
    Sanchez-Ramirez DC; Mackey D
    Respir Med; 2020 Sep; 171():106096. PubMed ID: 32763754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?
    Farsalinos K; Barbouni A; Niaura R
    Intern Emerg Med; 2020 Aug; 15(5):845-852. PubMed ID: 32385628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. More Than Meets the Eye: The Similarities Between Coronavirus Disease 2019 and Smoking.
    Lang AE; Yakhkind A
    Mayo Clin Proc; 2020 Oct; 95(10):2282-2283. PubMed ID: 33012356
    [No Abstract]   [Full Text] [Related]  

  • 30. Could the smoking gun in the fight against COVID-19 be the (rh)ACE-2?
    Lutchman D
    Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32398309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Smoking Is Associated With COVID-19 Progression: A Meta-analysis.
    Patanavanich R; Glantz SA
    Nicotine Tob Res; 2020 Aug; 22(9):1653-1656. PubMed ID: 32399563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low prevalence of bronchial asthma and chronic obstructive lung disease among intensive care unit patients with COVID-19.
    Avdeev S; Moiseev S; Brovko M; Yavorovskiy A; Umbetova K; Akulkina L; Tsareva N; Merzhoeva Z; Gainitdinova V; Fomin V
    Allergy; 2020 Oct; 75(10):2703-2704. PubMed ID: 32455491
    [No Abstract]   [Full Text] [Related]  

  • 33. Impact of coronavirus disease-2019 on chronic respiratory disease in South Korea: an NHIS COVID-19 database cohort study.
    Oh TK; Song IA
    BMC Pulm Med; 2021 Jan; 21(1):12. PubMed ID: 33407347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis.
    Zhao Q; Meng M; Kumar R; Wu Y; Huang J; Lian N; Deng Y; Lin S
    J Med Virol; 2020 Oct; 92(10):1915-1921. PubMed ID: 32293753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of heart failure on the outcome of COVID-19 - A meta analysis and systematic review.
    Yonas E; Alwi I; Pranata R; Huang I; Lim MA; Gutierrez EJ; Yamin M; Siswanto BB; Virani SS
    Am J Emerg Med; 2021 Aug; 46():204-211. PubMed ID: 33071085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of smoking, COPD and comorbidities on the mortality of COVID-19 patients.
    Lacedonia D; Scioscia G; Santomasi C; Fuso P; Carpagnano GE; Portacci A; Mastroianni F; Larizza G; Sabato E; Profilo E; Resta E; Foschino Barbaro MP; Resta O
    Sci Rep; 2021 Sep; 11(1):19251. PubMed ID: 34584165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 and the nicotinic cholinergic system.
    Farsalinos K; Angelopoulou A; Alexandris N; Poulas K
    Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32444400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of smoking history with severe and critical outcomes in COVID-19 patients: A systemic review and meta-analysis.
    Zhang H; Ma S; Han T; Qu G; Cheng C; Uy JP; Shaikh MB; Zhou Q; Song EJ; Sun C
    Eur J Integr Med; 2021 Apr; 43():101313. PubMed ID: 33619437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Smoking and comorbidities are associated with COVID-19 severity and mortality in 565 patients treated in Turkey: a retrospective observational study.
    Caliskan T; Saylan B
    Rev Assoc Med Bras (1992); 2020 Dec; 66(12):1679-1684. PubMed ID: 33331576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis.
    Huang I; Pranata R
    J Intensive Care; 2020; 8():36. PubMed ID: 32483488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.